Last updated on July 2018

Study on the Efficacy Safety and Tolerability of Cariprazine Relative to Placebo in Patients With Bipolar I Depression


Brief description of study

This study investigates the efficacy of a fixed-dose regimen of cariprazine 1.5 mg/day or 3 mg/day compared to placebo for treatment of the depressive episode in patients with bipolar I disorder. The safety and tolerability of the fixed-dose regimens will be evaluated.

Clinical Study Identifier: NCT02670551

Contact Investigators or Research Sites near you

Start Over

Clincial Trials Registry Team

Investigative Site 008
Little Rock, AR United States

Clincial Trials Registry Team

Investigative Site 005
Costa Mesa, CA United States

Clincial Trials Registry Team

Investigative Site 016
Escondido, CA United States

Clincial Trials Registry Team

Investigative Site 033
Long Beach, CA United States

Clincial Trials Registry Team

Investigative Site 041
Oakland, CA United States

Clincial Trials Registry Team

Investigative Site 002
San Diego, CA United States

Clincial Trials Registry Team

Investigative Site 027
Sherman Oaks, CA United States

Clincial Trials Registry Team

Investigative Site 017
Temecula, CA United States

Clincial Trials Registry Team

Investigative Site 044
Upland, CA United States

Clincial Trials Registry Team

Investigative Site 031
Norwich, CT United States

Clincial Trials Registry Team

Investigative Site 034
Jacksonville, FL United States

Clincial Trials Registry Team

Investigative Site 028
Orlando, FL United States

Clincial Trials Registry Team

Investigative Site 045
Tampa, FL United States

Clincial Trials Registry Team

Investigative Site 023
Atlanta, GA United States

Clincial Trials Registry Team

Investigative Site 032
Glendale, GA United States

Clincial Trials Registry Team

Investigative Site 007
Marietta, GA United States

Clincial Trials Registry Team

Investigative Site 022
Smyrna, GA United States

Clincial Trials Registry Team

Investigative Site 046
Skokie, IL United States

Clincial Trials Registry Team

Investigative Site 036
Winfield, IL United States

Clincial Trials Registry Team

Investigative Site 011
St. Charles, MO United States

Clincial Trials Registry Team

Investigative Site 040
Las Vegas, NV United States

Clincial Trials Registry Team

Investigative Site 001
Berlin, NJ United States

Clincial Trials Registry Team

Investigative Site 048
Cedarhurst, NY United States

Clincial Trials Registry Team

Investigative Site 010
New York, NY United States

Clincial Trials Registry Team

Investigative Site 006
Canton, OH United States

Clincial Trials Registry Team

Investigative Site 019
Cincinnati, OH United States

Clincial Trials Registry Team

Investigative Site 030
Cincinnati, OH United States

Clincial Trials Registry Team

Investigative Site 020
Columbus, OH United States

Clincial Trials Registry Team

Investigative Site 047
Dayton, OH United States

Clincial Trials Registry Team

Investigative Site 013
Oklahoma City, OK United States

Clincial Trials Registry Team

Investigative Site 003
Oklahoma City, OK United States

Clincial Trials Registry Team

Investigative Site 038
Portland, OR United States

Clincial Trials Registry Team

Investigative Site 018
Salem, OR United States

Clincial Trials Registry Team

Investigative Site 014
Allentown, PA United States

Clincial Trials Registry Team

Investigative Site 009
Lincoln, RI United States

Clincial Trials Registry Team

Investigative Site 015
Memphis, TN United States

Clincial Trials Registry Team

Investigative Site 026
Houston, TX United States

Clincial Trials Registry Team

Investigative Site 021
Houston, TX United States

Clincial Trials Registry Team

Investigative Site 035
Plano, TX United States

Clincial Trials Registry Team

Investigative Site 037
The Woodlands, TX United States

Clincial Trials Registry Team

Investigative Site 012
Richmond, VA United States

Clincial Trials Registry Team

Investigative Site 004
Bellevue, WA United States

Clincial Trials Registry Team

Investigative Site 042
Kirkland, WA United States

Clincial Trials Registry Team

Investigative Site 039
Seattle, WA United States

Clincial Trials Registry Team

Investigative Site 043
San Juan, Puerto Rico